Long-term outcome of thyroid abnormalities in patients with severe Covid-19

被引:6
|
作者
Muller, Ilaria [1 ,2 ]
Daturi, Anita [2 ]
Varallo, Matteo [2 ]
Re, Tiziana E. [3 ]
Dazzi, Davide [4 ]
Maioli, Sara [2 ]
Crivicich, Erica [2 ]
Di Marco, Francesco [2 ]
Longari, Virgilio [5 ]
Dazzi, Beatrice [1 ]
Castellani, Massimo [5 ]
Mantovani, Giovanna [1 ,2 ]
Arosio, Maura [1 ,2 ]
Salvi, Mario [1 ]
机构
[1] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Endocrinol Unit, Milan, Italy
[2] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy
[3] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Internal Med High Intens Care Unit, Milan, Italy
[4] Casa Cura Val Parma SRL Langhirano Parmigiano Lang, Langhirano, Italy
[5] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Nucl Med Unit, Milan, Italy
关键词
Covid-19; SARS-CoV-2; thyroiditis; thyroid; FUNCTION TESTS; HYPOTHYROIDISM; DEXAMETHASONE;
D O I
10.1530/ETJ-22-0200
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: We have previously observed thyroid dysfunction, i.e. atypical thyroiditis (painless thyrotoxicosis associated with non-thyroidal illness syndrome), in patients with severe acute respiratory syndrome coronavirus 2 disease (Covid-19). This study aimed to analyse the evolution of thyroid dysfunction over time.Methods: One hundred eighty-three consecutive patients hospitalised for severe Covid-19 without known thyroid history were studied at hospital admission (baseline). Survivors were offered 12-month longitudinal follow-up including assessment of thyroid function, autoantibodies and ultrasound scan (US). Patients showing US focal hypoechoic areas suggestive of thyroiditis (focal hypoechogenicity) also underwent thyroid Tc-99m or I-123 uptake scan.Results: At baseline, after excluding from TSH analysis, 63 out of 183 (34%) Covid-19 patients commenced on steroids before hospitalisation, and 12 (10%) showed atypical thyroiditis. Follow-up of 75 patients showed normalisation of thyroid function and inflammatory markers and no increased prevalence of detectable thyroid autoantibodies. Baseline US (available in 65 patients) showed focal hypoechogenicity in 28% of patients, of whom 82% had reduced thyroid Tc-99m/I-123 uptake. The presence of focal hypoechogenicity was associated with baseline low TSH (P = 0.034), high free-thyroxine (FT4) (P = 0.018) and high interleukin-6 (IL6) (P = 0.016). Focal hypoechogenicity persisted after 6 and 12 months in 87% and 50% patients, respectively, but reduced in size. After 9 months, thyroid Tc-99m/I-123 uptake partially recovered from baseline (+28%) but was still reduced in 67% patients.Conclusions: Severe Covid-19 induces mild transient thyroid dysfunction correlating with disease severity. Focal hypoechogenicity, associated with baseline high FT4, IL6 and low TSH, does not seem to be related to thyroid autoimmunity and may persist after 1 year although decreasing in size. Long-term consequences seem unlikely.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Fatigue as long-term consequence of ARDS in COVID-19 patients
    Zuin, Marco
    Rigatelli, Gianluca
    Zuliani, Giovanni
    Roncon, Loris
    ANAESTHESIA CRITICAL CARE & PAIN MEDICINE, 2021, 40 (01)
  • [32] Editorial: Translational research in severe COVID-19 and long-term symptoms post-COVID-19
    Vicens-Zygmunt, Vanesa
    Perez-Rubio, Gloria
    Chavez-Galan, Leslie
    Buendia-Roldan, Ivette
    Falfan-Valencia, Ramces
    FRONTIERS IN MEDICINE, 2023, 10
  • [33] Vaccination status and long COVID symptoms among patients hospitalized with COVID-19: the WHF COVID-19 Long-term Study
    Singh, K.
    Prabhakaran, D.
    Nikhare, K.
    Raspail, L.
    Banerjee, A.
    Narula, J.
    Pineiro, D.
    Perel, P.
    Sliwa Hahnle, K.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [34] Workers at long-term care facilities and their risk for severe COVID-19 illness
    Greene, Jessica
    Gibson, Diane M.
    PREVENTIVE MEDICINE, 2021, 143
  • [35] Thyroid dysfunction as a long-term post-COVID-19 complication in mild-to-moderate COVID-19
    Yanachkova, Vesselina
    Stankova, Teodora
    Staynova, Radiana
    BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT, 2023, 37 (01) : 194 - 202
  • [36] Cardiopulmonary long-term sequelae in patients 6 and 18 months after severe Covid-19 disease
    Niebauer, J. H.
    Iscel, A.
    Schedl, S.
    Capelle, C.
    Schamilow, S.
    Kahr, M.
    Charwat-Resl, S.
    Krestan, C.
    Valenta, R.
    Hoffmann, S.
    Badr-Eslam, R.
    Zoufaly, A.
    Wenisch, C.
    Hitzl, W.
    Lichtenauer, M.
    Bonderman, D.
    WIENER KLINISCHE WOCHENSCHRIFT, 2023, 135 : S437 - S438
  • [37] Tracheomegaly as a Potential Predictor of Severe Tracheal Damage in COVID-19 Patients on Long-Term Mechanical Ventilation
    Tarle, Marko
    Raguz, Marina
    Derke, Filip
    Oreskovic, Darko
    Persec, Jasminka
    Luksic, Ivica
    COVID, 2022, 2 (06): : 719 - 730
  • [38] Cardiopulmonary long-term impairment in patients 6 and 18 months post severe Covid-19 infection
    Niebauer, J. H.
    Iscel, A.
    Schedl, S.
    Capelle, C.
    Kahr, M.
    Schamilow, S.
    Badr-Eslam, R.
    Lichtenauer, M.
    Zoufaly, A.
    Valenta, R.
    Charwat-Resl, S.
    Krestan, C.
    Hitzl, W.
    Wenisch, C.
    Bonderman, D.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [39] Survival After Severe COVID-19: Long-Term Outcomes of Patients Admitted to an Intensive Care Unit
    Neville, Thanh H.
    Hays, Ron D.
    Tseng, Chi-Hong
    Gonzalez, Cynthia A.
    Chen, Lucia
    Hong, Ashley
    Yamamoto, Myrtle
    Santoso, Laura
    Kung, Alina
    Schwab, Kristin
    Chang, Steve Y.
    Qadir, Nida
    Wang, Tisha
    Wenger, Neil S.
    JOURNAL OF INTENSIVE CARE MEDICINE, 2022, 37 (08) : 1019 - 1028
  • [40] Short- and Long-Term Recovery after Moderate/Severe AKI in Patients with and without COVID-19
    Sun, Siao
    Annadi, Raji R.
    Chaudhri, Imran
    Munir, Kiran
    Hajagos, Janos
    Saltz, Joel
    Hoai, Minh
    Mallipattu, Sandeep K.
    Moffitt, Richard
    Koraishy, Farrukh M.
    KIDNEY360, 2022, 3 (02): : 242 - 257